Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1877754 | Applied Radiation and Isotopes | 2011 | 4 Pages |
Abstract
Clear cell sarcoma (CCS) is a rare melanocytic malignant tumor with a poor prognosis. Our previous study demonstrated that in vitro cultured CCS cells have the ability to highly uptake l-BPA and thus boron neutron capture therapy could be a new option for CCS treatment. This paper proved that a remarkably high accumulation of 10B (45–74 ppm) in tumor was obtained even in a CCS-bearing animal with a well-controlled biodistribution followed by intravenous administration of l-BPA-fructose complex (500 mg BPA/kg).
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
T. Andoh, T. Fujimoto, T. Sudo, I. Fujita, M. Imabori, H. Moritake, T. Sugimoto, Y. Sakuma, T. Takeuchi, S. Kawabata, M. Kirihata, T. Akisue, K. Yayama, M. Kurosaka, S. Miyatake, Y. Fukumori, H. Ichikawa,